Insider · CIK 0001930479
Jill DeSimone
Files at ONCT (Oncternal Therapeutics, Inc.), PRAX (Praxis Precision Medicines, Inc.), KNTE (Kinnate Biopharma Inc.), ITOS (iTeos Therapeutics, Inc.). First filing Jun 26, 2026, latest Jun 26, 2026.
In brief
Jill DeSimone files SEC Form 4 as director at PRAX (Praxis Precision Medicines, Inc.), and also at ONCT (Oncternal Therapeutics, Inc.), KNTE (Kinnate Biopharma Inc.), ITOS (iTeos Therapeutics, Inc.). Since Jun 26, 2026, Jill DeSimone has reported 0 open-market buys worth $0 and 1 open-market sell worth $3.6M, the latest filed on Jun 26, 2026.
A track record needs three past buys with six months of prices behind them; Jill DeSimone has 0, so none is measured yet.
The newest scored trade: sold $3.6M of PRAX on Jun 24, 2026, filed Jun 26, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $3.6M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PRAX: Praxis Precision Medicines, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Praxis Precision Medicines, Inc. | $3.6M 11,600 shares | -83% | +719% from low-13% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | 11,600 0.04% of outstanding | $3.6M | Jun 24, 2026 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | MOption exercise Common Stock10b5-1 | +8,566 | $44.25 | $379k | 10,903 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | MOption exercise Common Stock10b5-1 | +3,034 | $147.30 | $447k | 13,937 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -10 | $301.44 | $3,014 | 13,927 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -120 | $303.13 | $36k | 13,807 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -320 | $305.31 | $98k | 13,487 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -683 | $306.77 | $210k | 12,804 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,240 | $308.24 | $382k | 11,564 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -999 | $309.38 | $309k | 10,565 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,750 | $310.89 | $544k | 8,815 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,854 | $311.91 | $890k | 5,961 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,004 | $312.83 | $314k | 4,957 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -504 | $313.66 | $158k | 4,453 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -1,279 | $314.90 | $403k | 3,174 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -837 | $315.71 | $264k | 2,337 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,566 | $0.00 | $0 | 0 | Jun 26, 2026 |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,034 | $0.00 | $0 | 0 | Jun 26, 2026 |
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc. | AGrant or award Common Stock | +1,371 | $0.00 | $0 | 2,337 | Jun 12, 2026 |
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +648 | $0.00 | $0 | 648 | Jun 12, 2026 |
| Jun 26, 2025 | PRAX Praxis Precision Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,520 | $0.00 | $0 | 10,520 | Jun 27, 2025 |
| Jun 20, 2024 | ONCT Oncternal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +2,200 | $0.00 | $0 | 2,200 | Jun 24, 2024 |
| Jun 11, 2024 | ITOS iTeos Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +24,200 | $0.00 | $0 | 24,200 | Jun 13, 2024 |
| Jun 5, 2024 | PRAX Praxis Precision Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,566 | $0.00 | $0 | 8,566 | Jun 6, 2024 |
| Apr 3, 2024 | KNTE Kinnate Biopharma Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -50,000 | - | - | 0 | Apr 5, 2024 |
| Mar 7, 2024 | ITOS iTeos Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +44,766 | $0.00 | $0 | 44,766 | Mar 7, 2024 |
| Jun 28, 2023 | ONCT Oncternal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2023 |
| Jun 12, 2023 | PRAX Praxis Precision Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +28,981 | $0.00 | $0 | 28,981 | Jun 14, 2023 |
| Mar 1, 2023 | KNTE Kinnate Biopharma Inc. | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Mar 3, 2023 |
| Jan 4, 2023 | ONCT Oncternal Therapeutics, Inc. | AGrant or award Stock Optionderivative | +50,000 | $0.00 | $0 | 50,000 | Jan 5, 2023 |
Questions about Jill DeSimone
Answered from the filings on this page, as of the latest one.
Is Jill DeSimone buying or selling?
In the last 12 months Jill DeSimone reported 0 open-market buys worth $0 and 1 open-market sell worth $3.6M on SEC Form 4; the latest was sold $3.6M of PRAX on Jun 24, 2026. Grants, option exercises and tax withholding are not counted.
How did Jill DeSimone's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jill DeSimone has 0.
Where does Jill DeSimone file Form 4?
Jill DeSimone has filed Form 4 at PRAX (Praxis Precision Medicines, Inc.); ONCT (Oncternal Therapeutics, Inc.); KNTE (Kinnate Biopharma Inc.); ITOS (iTeos Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.